CMRX Chimerix, Inc. Stock Quote

CMRX [NASD]

Index	-	P/E	-	EPS (ttm)	-0.57	Insider Own	0.20%	Shs Outstand	62.24M	Perf Week	13.29%
Market Cap	596.41M	Forward P/E	-	EPS next Y	-0.75	Insider Trans	-10.41%	Shs Float	51.15M	Perf Month	79.17%
Income	-35.40M	PEG	-	EPS next Q	-0.20	Inst Own	53.30%	Short Float	1.74%	Perf Quarter	234.59%
Sales	11.00M	P/S	54.22	EPS this Y	-41.90%	Inst Trans	0.40%	Short Ratio	0.88	Perf Half Y	155.05%
Book/sh	1.34	P/B	6.97	EPS next Y	-5.60%	ROA	-33.50%	Target Price	9.67	Perf Year	364.43%
Cash/sh	1.37	P/C	6.80	EPS next 5Y	-	ROE	-36.50%	52W Range	1.19 - 9.66	Perf YTD	93.27%
Dividend	-	P/FCF	-	EPS past 5Y	-2.40%	ROI	-105.20%	52W High	-3.36%	Beta	1.86
Dividend %	-	Quick Ratio	12.20	Sales past 5Y	25.40%	Gross Margin	-	52W Low	684.45%	ATR	0.73
Employees	43	Current Ratio	12.20	Sales Q/Q	-20.00%	Oper. Margin	-	RSI (14)	79.48	Volatility	10.22% 9.29%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	85.50%	Profit Margin	-	Rel Volume	7.34	Prev Close	9.13
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Nov 05 BMO	Payout	-	Avg Volume	1.01M	Price	9.34
Recom	2.30	SMA20	48.14%	SMA50	89.94%	SMA200	180.08%	Volume	6,623,540	Change	2.25%

Feb-14-18

Downgrade

JP Morgan

Neutral → Underweight

Feb-02-18

Initiated

H.C. Wainwright

Buy

$10

Aug-09-16

Reiterated

FBR Capital

Mkt Perform

$9 → $8

Feb-23-16

Reiterated

FBR Capital

Mkt Perform

$14 → $10

Feb-23-16

Downgrade

Morgan Stanley

Equal-Weight → Underweight

Feb-23-16

Downgrade

Barclays

Overweight → Equal Weight

$12 → $6

Feb-22-16

Downgrade

Citigroup

Buy → Neutral

Dec-29-15

Downgrade

JP Morgan

Overweight → Neutral

$65 → $15

Dec-28-15

Reiterated

Piper Jaffray

Overweight

$63 → $10

Dec-28-15

Downgrade

FBR Capital

Outperform → Mkt Perform

$73 → $14

Dec-17-15

Initiated

UBS

Buy

$55

Oct-05-15

Downgrade

Morgan Stanley

Overweight → Equal-Weight

Sep-03-15

Initiated

Citigroup

Buy

Aug-18-15

Initiated

FBR Capital

Outperform

$73

Aug-06-15

Reiterated

Brean Capital

Buy

$50 → $57

May-11-15

Reiterated

Brean Capital

Buy

$45 → $50

Mar-04-15

Initiated

Barclays

Overweight

$55

Feb-12-15

Reiterated

Stifel

Buy

$47 → $57

Dec-31-14

Reiterated

Brean Capital

Buy

$33 → $45

Jul-08-14

Resumed

Brean Capital

Buy

$33

Jan-20-21 08:03PM	Chimerix Announces Pricing of Public Offering of Common Stock GlobeNewswire +12.72%
Jan-19-21 04:19PM	Chimerix Announces Proposed $75,000,000 Public Offering of Common Stock GlobeNewswire
Jan-11-21 10:29AM	Company News for Jan 11, 2021 Zacks
Jan-08-21 07:48PM	Why Chimerix Stock Skyrocketed on Friday Motley Fool +69.08%
04:25PM	TripAdvisor, Acacia, WD-40: 5 Top Stock Gainers for Friday TheStreet.com
07:25AM	The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs Benzinga
06:00AM	Chimerix Acquires Oncoceutics to Expand Pipeline with Late-Stage Oncology Program GlobeNewswire
Jan-06-21 08:00AM	Chimerix to Present at Virtual H.C. Wainwright BioConnect 2021 Conference GlobeNewswire
Dec-22-20 12:41AM	Did Business Growth Power Chimerix's (NASDAQ:CMRX) Share Price Gain of 141%? Simply Wall St.
Dec-12-20 10:30PM	Is CMRX A Good Stock To Buy Now? Insider Monkey
Dec-08-20 08:56AM	Chimerx's (CMRX) NDA for Brincidofovir Accepted by FDA Zacks +12.33%
Dec-07-20 07:00AM	Chimerix Announces FDA Acceptance of New Drug Application for Brincidofovir as a Medical Countermeasure for Smallpox GlobeNewswire +25.41%
Nov-07-20 08:33AM	Analysts Have Lowered Expectations For Chimerix, Inc. (NASDAQ:CMRX) After Its Latest Results Simply Wall St.
Nov-06-20 05:50AM	Revenue Downgrade: Here's What Analysts Forecast For Chimerix, Inc. (NASDAQ:CMRX) Simply Wall St.
Nov-05-20 04:01PM	Chimerix to Present at Credit Suisse 29th Annual Healthcare Conference GlobeNewswire
07:00AM	Chimerix Reports Third Quarter 2020 Financial Results and Provides Operational Update GlobeNewswire
Oct-29-20 07:00AM	Chimerix to Report Third Quarter 2020 Financial Results and Provide an Operational Update on November 5, 2020 GlobeNewswire
Oct-28-20 08:12AM	Did Chimerix, Inc. (NASDAQ:CMRX) Insiders Buy Up More Shares? Simply Wall St.
Sep-13-20 10:21AM	What Kind Of Shareholders Own Chimerix, Inc. (NASDAQ:CMRX)? Simply Wall St.
Sep-10-20 08:00AM	Chimerix to Participate in Upcoming Investor Conferences GlobeNewswire
Aug-10-20 08:25AM	Chimerix (CMRX) Reports Q2 Loss, Tops Revenue Estimates Zacks
07:28AM	Recap: Chimerix Q2 Earnings Benzinga
07:00AM	Chimerix Reports Second Quarter 2020 Financial Results and Provides Operational Update GlobeNewswire
Aug-03-20 08:00AM	Chimerix to Report Second Quarter 2020 Financial Results and Provide an Operational Update on August 10, 2020 GlobeNewswire
Jul-15-20 12:22PM	Will Chimerix (NASDAQ:CMRX) Spend Its Cash Wisely? Simply Wall St. +7.31%
Jul-05-20 02:43PM	Here is What Hedge Funds Think About Chimerix Inc (CMRX) Insider Monkey
Jun-22-20 07:00AM	Chimerix Appoints Allen Melemed, M.D. as Chief Medical Officer GlobeNewswire +5.79%
Jun-18-20 08:00AM	Chimerix to Present at H.C. Wainwright Virtual Fireside Chat Series GlobeNewswire
May-28-20 08:00AM	Chimerix to Present at Jefferies Virtual Healthcare Conference GlobeNewswire -9.66%
May-12-20 06:47AM	Revenue Downgrade: Here's What Analysts Forecast For Chimerix, Inc. (NASDAQ:CMRX) Simply Wall St.
May-07-20 10:25AM	Chimerix (CMRX) Reports Q1 Loss, Lags Revenue Estimates Zacks +9.52%
09:07AM	Recap: Chimerix Q1 Earnings Benzinga
07:00AM	Chimerix Reports First Quarter 2020 Financial Results and Provides Operational Update GlobeNewswire
May-02-20 08:40AM	One Thing To Remember About The Chimerix, Inc. (NASDAQ:CMRX) Share Price Simply Wall St.
Apr-29-20 07:00AM	Chimerix Announces Initiation of a Phase 2/3 Study of DSTAT in Acute Lung Injury for Patients with Severe COVID-19 GlobeNewswire +42.38%
Apr-28-20 04:30PM	Chimerix Receives FDA Clearance for Rolling Submission of New Drug Application for Brincidofovir as a Medical Countermeasure for Smallpox GlobeNewswire
Mar-26-20 08:18AM	Edited Transcript of CMRX earnings conference call or presentation 25-Feb-20 1:30pm GMT Thomson Reuters StreetEvents +7.86%
Mar-18-20 06:26AM	Michael Sherman Is The CEO, President & Director of Chimerix, Inc. (NASDAQ:CMRX) And They Just Spent US$106k On Shares Simply Wall St. -15.89%
Feb-28-20 12:00PM	All You Need to Know About Chimerix (CMRX) Rating Upgrade to Buy Zacks
Feb-26-20 08:00AM	Chimerix to Present at Cowen and Company 40th Annual Health Care Conference GlobeNewswire -7.00%
Feb-25-20 07:00AM	Chimerix Reports Fourth Quarter and Year End 2019 Financial Results and Provides Operational Update GlobeNewswire +15.61%
06:30AM	Chimerix, Inc. to Host Earnings Call ACCESSWIRE
Feb-24-20 08:00AM	Chimerix Appoints Pratik S. Multani, M.D., to Board of Directors GlobeNewswire
Feb-18-20 08:00AM	Chimerix to Report Fourth Quarter and Year End 2019 Financial Results and Provide an Operational Update on February 25, 2020 GlobeNewswire +5.39%
Feb-06-20 07:04AM	Investors Who Bought Chimerix (NASDAQ:CMRX) Shares Five Years Ago Are Now Down 96% Simply Wall St.
Feb-05-20 11:52AM	Steven Cohen Renews His Interest in Verastem GuruFocus.com
Jan-29-20 08:00AM	Chimerix Presents Data Supporting Brincidofovir as a Potential Treatment for Smallpox at 2020 American Society for Microbiology Biothreats Meeting GlobeNewswire
Jan-03-20 11:30AM	Has Chimerix (CMRX) Outpaced Other Medical Stocks This Year? Zacks +7.18%
Dec-23-19 06:12AM	Here's Why We're Watching Chimerix's (NASDAQ:CMRX) Cash Burn Situation Simply Wall St.
Dec-16-19 01:04AM	New Trade Deal, New Records for S&P and NASDAQ Zacks
Dec-14-19 08:59PM	Is Chimerix Inc (CMRX) A Good Stock To Buy? Insider Monkey
Dec-10-19 07:30AM	Chimerix Presents Updated Results from Phase 2 Clinical Trial of DSTAT in Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia at American Society of Hematology Annual Meeting GlobeNewswire -20.16%
Dec-04-19 01:01AM	Stocks Not Happy About Talk of Trade Deal Delay Zacks -6.99%
Nov-22-19 12:02AM	Edited Transcript of CMRX earnings conference call or presentation 5-Nov-19 1:30pm GMT Thomson Reuters StreetEvents
Nov-07-19 06:19AM	Should You Be Concerned About Chimerix, Inc.'s (NASDAQ:CMRX) Historical Volatility? Simply Wall St. +6.49%
Nov-05-19 07:00AM	Chimerix Announces Third Quarter 2019 Financial Results and Provides Operational Update GlobeNewswire +8.22%
Nov-04-19 04:01PM	Chimerix to Present at Upcoming Investor Conferences GlobeNewswire -7.01%
Oct-29-19 08:00AM	Chimerix to Announce Third Quarter 2019 Financial Results and Provide an Operational Update on November 5, 2019 GlobeNewswire
Oct-02-19 08:47AM	Have Insiders Been Buying Chimerix, Inc. (NASDAQ:CMRX) Shares? Simply Wall St.
Oct-01-19 08:10AM	The Daily Biotech Pulse: Safety Scare For Anaptys' Psoriasis Drug, NewLink Genetics To Merge With Lumos, Insider Buy Props Up VBI Vaccines Benzinga -13.62%
Sep-30-19 07:30PM	Chimerix Announces Exclusive Global License Agreement with SymBio Pharmaceuticals for Brincidofovir GlobeNewswire -6.00%
Sep-27-19 08:00AM	Chimerix to Present at 2019 Cantor Global Healthcare Conference GlobeNewswire
Aug-27-19 01:13PM	Those Who Purchased Chimerix (NASDAQ:CMRX) Shares Five Years Ago Have A 91% Loss To Show For It Simply Wall St.
Aug-08-19 09:35AM	Chimerix (CMRX) Reports Q2 Loss, Lags Revenue Estimates Zacks
08:00AM	Chimerix Announces Second Quarter 2019 Financial Results and Operational Update GlobeNewswire
Aug-07-19 10:30AM	Chimerix (CMRX) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release Zacks
Aug-05-19 07:55AM	Durham pharma spends $30 million for rights to potential Leukemia treatment American City Business Journals -11.52%
Jul-31-19 07:00AM	Chimerix Announces Exclusive Worldwide License of Phase 3 Ready CX-01 for Development in Acute Myeloid Leukemia GlobeNewswire
Jul-12-19 03:07PM	Do Institutions Own Chimerix, Inc. (NASDAQ:CMRX) Shares? Simply Wall St.
Jun-28-19 06:41PM	Did Hedge Funds Drop The Ball On Chimerix Inc (CMRX) ? Insider Monkey +19.01%
May-17-19 08:18AM	Edited Transcript of CMRX earnings conference call or presentation 9-May-19 12:30pm GMT Thomson Reuters StreetEvents
May-16-19 09:11AM	Will Chimerix to Surge Higher? Zacks
May-09-19 09:25AM	Chimerix (CMRX) Reports Q1 Loss, Tops Revenue Estimates Zacks +7.49%
08:25AM	Chimerix: 1Q Earnings Snapshot Associated Press
08:00AM	Chimerix Announces First Quarter 2019 Financial Results and Strategy Update GlobeNewswire
06:30AM	Chimerix, Inc. to Host Earnings Call ACCESSWIRE
May-02-19 04:01PM	Chimerix to Announce First Quarter 2019 Financial Results on May 9, 2019 GlobeNewswire
Apr-29-19 10:31AM	Will Chimerix (CMRX) Report Negative Q1 Earnings? What You Should Know Zacks +6.20%
Apr-12-19 01:43PM	One Thing To Remember About The Chimerix, Inc. (NASDAQ:CMRX) Share Price Simply Wall St. -7.24%
Apr-09-19 11:21AM	Chimerix taps former Endocyte executive as new CEO American City Business Journals +31.10%
08:10AM	The Daily Biotech Pulse: PhaseBio Gets Breakthrough Therapy Designation, FDA Shoots Down Zogenix Epilepsy Regulatory Filing Benzinga
Apr-08-19 05:00PM	Chimerix Announces Management Updates GlobeNewswire
Apr-05-19 02:14PM	Again, Durham pharma loses a drug development partner American City Business Journals
Mar-26-19 06:30PM	Edited Transcript of CMRX earnings conference call or presentation 5-Mar-19 1:30pm GMT Thomson Reuters StreetEvents +7.43%
Mar-07-19 12:24PM	Should You Be Worried About Insider Transactions At Chimerix, Inc. (NASDAQ:CMRX)? Simply Wall St.
Mar-05-19 07:00AM	Chimerix Announces Fourth Quarter and Full Year 2018 Financial Results GlobeNewswire -16.09%
Mar-04-19 08:00AM	Chimerix to Present at Cowen and Company 39th Annual Health Care Conference GlobeNewswire
Feb-26-19 08:00AM	Chimerix to Announce Fourth Quarter and Full Year 2018 Financial Results on March 5, 2019 GlobeNewswire
Feb-22-19 08:00AM	Chimerix Presents Results from Post-hoc Analysis of Phase 3 Study GlobeNewswire
Feb-14-19 08:15AM	Chimerix filing reveals ex-CEO's severance package after sudden resignation American City Business Journals -7.08%
Feb-11-19 07:55AM	New Research Coverage Highlights United Parcel Service, Healthcare Trust of America, CommVault, SPX FLOW, Chimerix, and International Speedway Consolidated Revenues, Company Growth, and Expectations for 2019 GlobeNewswire
Feb-06-19 02:20PM	Sudden Departure: Chimerix CEO, board member resigns American City Business Journals
08:00AM	Chimerix Announces Management Transition GlobeNewswire
Jan-30-19 11:51AM	What Type Of Shareholder Owns Chimerix, Inc.s (NASDAQ:CMRX)? Simply Wall St. +11.68%
Jan-24-19 10:17AM	Will Overall Growth Aid Thermo Fisher's (TMO) Q4 Earnings? Zacks
10:03AM	Can Solid Consumables Drive Illumina's (ILMN) Q4 Earnings? Zacks
Jan-18-19 06:36AM	What Lies Ahead for Abbott (ABT) Stock This Earnings Season? Zacks -6.57%
Jan-17-19 09:38AM	4 Medical Product Stocks Likely to Top Q4 Earnings Estimates Zacks
Jan-04-19 07:30AM	Chimerix to Present at the 37th Annual J.P. Morgan Healthcare Conference GlobeNewswire +7.14%
Dec-27-18 09:23AM	Stocks down in December for pharma firms in the Triangle American City Business Journals +6.52%

Chimerix, Inc., a development-stage biopharmaceutical company, focuses on accelerating the advancement of various medicines that impact in the lives of patients living with cancer and other serious diseases. Its clinical stage development programs include dociparstat sodium (DSTAT), a potential first-in-class glycosaminoglycan compound derived from porcine heparin that has low anticoagulant activity but retains the ability to inhibit activities of key proteins implicated in the retention and viability of acute myeloid leukemia blasts and leukemic stem cells in the bone marrow during chemotherapy; and brincidofovir (BCV), an antiviral drug candidate in development as a medical countermeasure for smallpox. The company has license agreements with Biomedical Advanced Research and Development Authority for the development of brincidofovir for use in the treatment of smallpox; Cantex Pharmaceuticals, Inc. to develop and commercialize a glycosaminoglycan compound; SymBio Pharmaceuticals to develop, manufacture, and commercialize BCV for various human indications; and University of Michigan to research, develop, manufacture, and commercialize various products. Chimerix, Inc. was founded in 2000 and is headquartered in Durham, North Carolina.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
DEMSKI MARTHA J	Director	Nov 17	Option Exercise	2.35	7,042	16,549	7,042	Nov 19 12:57 PM
Jakeman David	Principal Accounting Officer	Oct 02	Sale	2.48	4,270	10,590	85,117	Oct 02 04:06 PM
Meyer Robert J.	Director	Aug 19	Buy	2.92	3,500	10,220	13,500	Aug 19 05:34 PM
DEMSKI MARTHA J	Director	Aug 10	Option Exercise	3.16	1,584	5,005	1,584	Aug 11 05:49 PM
DEMSKI MARTHA J	Director	Aug 10	Sale	3.25	1,584	5,148	0	Aug 11 05:49 PM
DEMSKI MARTHA J	Director	Aug 07	Option Exercise	3.16	2,500	7,900	2,500	Aug 10 05:54 PM
DEMSKI MARTHA J	Director	Aug 07	Sale	3.25	2,500	8,125	0	Aug 10 05:54 PM
DEMSKI MARTHA J	Director	Aug 06	Option Exercise	3.16	2,500	7,900	2,500	Aug 10 05:54 PM
DEMSKI MARTHA J	Director	Aug 06	Sale	3.29	2,500	8,224	0	Aug 10 05:54 PM
DEMSKI MARTHA J	Director	Aug 05	Option Exercise	3.16	2,500	7,900	2,500	Aug 06 12:55 PM
DEMSKI MARTHA J	Director	Aug 05	Sale	3.27	2,500	8,187	0	Aug 06 12:55 PM
DEMSKI MARTHA J	Director	Aug 04	Option Exercise	3.16	5,000	15,800	5,000	Aug 06 12:55 PM
DEMSKI MARTHA J	Director	Aug 04	Sale	3.25	5,000	16,250	0	Aug 06 12:55 PM
Andriole Michael T.	Chief Business Officer	Mar 16	Buy	1.43	33,300	47,522	149,729	Mar 17 11:58 AM
MIDDLETON FRED A	Director	Mar 12	Buy	1.40	50,000	69,900	197,523	Mar 16 12:19 PM
Sherman Michael A.	Chief Executive Officer	Mar 12	Buy	1.45	72,995	105,653	102,995	Mar 16 12:51 PM
Nichols Garrett	Chief Medical Officer	Feb 10	Sale	1.68	8,805	14,830	260,066	Feb 11 04:19 PM
Nichols Garrett	Chief Medical Officer	Feb 07	Sale	1.70	2,550	4,335	268,871	Feb 11 04:19 PM
Jakeman David	Principal Accounting Officer	Feb 07	Sale	1.70	2,290	3,893	87,876	Feb 11 04:16 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience